Former Chinese Nationalist Party (KMT) vice chairman Hau Lung-bin (郝龍斌) is to appeal the Food and Drug Administration’s (FDA) authorization of Medigen Vaccine Biologics’ COVID-19 vaccine, he said yesterday.
The administration on July 19 granted Medigen emergency use authorization, even though the drugmaker had not yet completed phase 3 clinical trials.
The government should not authorize the use of a vaccine that has not completed phase 3 trials, Hau said in Taipei on the sidelines of an event to distribute boxed meals with former president Ma Ying-jeou (馬英九) and Broadcasting Corp of China chairman Jaw Shaw-kong (趙少康).
Photo: Fang Pin-chao, Taipei Times
Hau said the government had politicized science in its hasty approval of a domestically developed COVID-19 vaccine.
The emergency use authorization of a vaccine prior to the completion of phase 3 trials is unprecedented, as it means a vaccine’s efficacy has not been verified, he said, adding that President Tsai Ing-wen (蔡英文) and Vice President William Lai (賴清德) have set a poor example in saying they would take the Medigen vaccine.
“The government should spare the lives of the Taiwanese people,” he said.
Minister of Health and Welfare Chen Shih-chung (陳時中), who heads the Central Epidemic Command Center, yesterday said that the center respects the right of citizens to file petitions related to the authorization.
Medigen is the only Taiwanese company to which the FDA has granted emergency use authorization.
The administration said it based its decision on data Medigen obtained in a phase 2 clinical trial of about 4,000 participants earlier this year, which was analyzed through immunobridging and compared with a control group of 200 recipients of the AstraZeneca COVID-19 vaccine in Taoyuan.
Immunobridging is a method to infer the efficacy of a vaccine by comparing the concentration of neutralizing antibodies in each group of recipients with that of an approved vaccine.
Medigen on July 20 announced that it had received permission to conduct a 1,000-person phase 3 clinical trial in Paraguay for its COVID-19 vaccine.
Participants in the trial, to be held with the National University of Asuncion’s medical school, would be recruited in the third quarter of this year and Medigen expects to have interim analysis data in the fourth quarter, the company said.
The trial would compare recipients of the Medigen and AstraZeneca vaccines through immunobridging, it said.
Medigen did not elaborate on its reasons for holding such a small trial or its use of immunobridging, which has been criticized as an insufficient substitute for traditional efficacy data.
Taiwan has agreed to buy 10 million doses of COVID-19 vaccines from two Taiwanese manufacturers: Medigen and United Biomedical, which has not yet been granted emergency use authorization by the FDA.
UNDER WATCH: Taiwan will have to establish a standardized nucleic acid testing method to identify the virus and monitor its spread, the CDC said The Langya henipavirus, which can be transmitted from animals to humans, has been discovered in China, with 35 human infections reported so far, Taiwan’s Centers for Disease Control (CDC) said, adding that the nation would establish a nucleic acid testing method to identify the virus. A study titled “A Zoonotic Henipavirus in Febrile Patients in China” that was published in the New England Journal of Medicine on Thursday said that a new henipavirus associated with a fever-causing human illness was identified in China. The study said an investigation identified 35 patients with acute infection of the Langya henipavirus in China’s Shandong
MISSILE PATHS: Certain information on the Chinese missile fire was not disclosed to maintain secrecy over military intelligence-gathering capabilities, the MND said Military experts yesterday speculated on the implication of the government’s tight-lipped response and the lack of air-raid sirens during the first day of China’s military drills the previous day. On Thursday, the Chinese People’s Liberation Army (PLA) launched 11 Dongfeng-series ballistic missiles into waters north, east and south of Taiwan, a day after US House of Representative Speaker Nancy Pelosi’s departure from the country, the Ministry of National Defense (MND) said. The Japanese Ministry of Defense said that China fired nine missiles toward Taiwan, including four that flew over Taiwan proper. However, China’s exhibition of force failed to terrorize the local populace, because
If any war were to break out between the US and China, one trigger might be the increasingly frequent fighter jet encounters near Taiwan. Almost every day, Taiwanese fighter pilots hop in their US-made F-16s to intercept Chinese warplanes screaming past their territory. The encounters probe the nation’s defenses and force the pilots on both sides to avoid mistakes that could lead to a crisis that spins out of control. “I didn’t know whether they would fire at me,” said retired colonel Mountain Wang, recounting a tense five-minute confrontation he had with Chinese People’s Liberation Army (PLA) jets more than a decade
INCREASINGLY EMBOLDENED: China can no longer be dismissed as inexperienced, demonstrating an ability to coordinate land and sea missile systems, an expert said Beijing’s largest-ever exercises around Taiwan have offered essential clues into its plans for a grueling blockade in the event of an attack on Taiwan, and revealed an increasingly emboldened Chinese military, experts said. The visit to Taiwan by US House of Representatives Speaker Nancy Pelosi — second in line to the presidency — sparked outrage from Beijing, which launched vast military maneuvers around the nation, even at the risk of partially exposing its plans to the US and its Asian allies. Mobilizing fighter planes, helicopters and warships, the drills aim to simulate a blockade of Taiwan and include practicing an “attack on